文献速递免疫规划传染病防控与疫情报告

男男性行为者自报猴痘疫苗接种状态的验证

Validation of self-reported mpox vaccination in men who have sex with men.
PubMed 文献 · Vaccine · 2026-10-01

澳大利亚在墨尔本性健康中心对6050名男男性行为者开展回顾性横断面研究,比较自报猴痘疫苗接种与电子健康记录。自报接种敏感性96.9%、特异性65.4%、准确率74.3%,阳性预测值52.4%、阴性预测值98.2%。自报对确认未接种可靠,但识别接种者可靠性较低,强调电子记录验证的必要性。

要点

  • 自报猴痘疫苗接种敏感性高(96.9%),可有效排除未接种者。
  • 自报接种特异性仅65.4%,阳性预测值52.4%,识别接种者易误分类。
  • 疫苗监测应以电子健康记录验证为准,不宜仅依赖自报。

核心结论

  • 多数男男性行为者能正确报告猴痘疫苗接种状态。
  • 自报接种对确认未接种可靠,但对识别已接种者可靠性较低。
  • 准确疫苗监测需电子健康记录验证。

研究设计与样本

  • 通过计算机辅助自访(CASI)收集自报猴痘疫苗接种状态,并与经验证的电子健康记录比较。
  • 计算敏感性、特异性、阳性预测值、阴性预测值、准确率及一致性(κ)。

主要发现

  • 5885名男性自报接种状态:48.6%(n=2859)已接种,44.6%(n=2623)未接种,6.8%(n=403)不确定。
  • 自报接种敏感性96.9%(95%CI:95.9%至97.7%),特异性65.4%(95%CI:63.9%至66.9%)。
  • 阳性预测值52.4%(95%CI:50.6%至54.3%),阴性预测值98.2%(95%CI:97.6%至98.6%),准确率74.3%(95%CI:73.1%至75.5%)。
  • 一致性为中等,提示存在残余误分类及电子健康记录对接种的不完全捕获。

临床怎么用

  • 在猴痘疫苗监测中,自报阴性可用于快速排除未接种,但自报阳性应经电子健康记录核实。
  • 行为研究和监测若仅依赖自报接种状态,可能高估接种覆盖率。

局限性

  • 验证所用电子健康记录可能未完全捕获接种信息,影响准确性评估。
  • 研究仅限墨尔本性健康中心就诊的男男性行为者,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Australian Government introduced a nationwide mpox MVA-BN vaccine to all eligible individuals at higher risk of mpox exposure, specifically gay, bisexual, and other men who have sex with men (GBMSM). Self-reported vaccination status is commonly used in surveillance and behavioural research, but its accuracy for mpox vaccination is unknown. We conducted a retrospective cross-sectional study of GBMSM aged ≥16 years who attended the Melbourne Sexual Health Centre (MSHC) between 7 December 2023 and 31 December 2024. Self-reported mpox vaccination status using computer-assisted self-interviewing (CASI) was compared to verified electronic health records. Sensitivity, specificity, and agreement (κ) were calculated alongside other measures of performance. Of 6050 eligible men, 5885 men self-reported their mpox vaccination status: 48.6% (n = 2859) vaccinated, 44.6% (n = 2623) unvaccinated, and 6.8% (n = 403) unsure. Self-reported mpox vaccination had a sensitivity of 96.9% (95% CI: 95.9% to 97.7%), a specificity of 65.4% (95% CI: 63.9% to 66.9%), a positive predictive value of 52.4% (95% CI: 50.6% to 54.3%), a negative predictive value of 98.2% (95% CI: 97.6% to 98.6%), and an accuracy of 74.3% (95% CI: 73.1% to 75.5%). Our results demonstrated that the majority of GBMSM correctly reported their vaccination status. While self-reported mpox vaccination demonstrates high sensitivity, moderate agreement indicates residual misclassification and incomplete capture of vaccinations in the electronic health record used for validation. This suggests that while self-report is reliable for confirming non-vaccination, it is less reliable for identifying vaccinated individuals, underscoring the importance of electronic health record verification for accurate vaccine surveillance.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mozaffari F, Aung ET, Soe NN, et al. Validation of self-reported mpox vaccination in men who have sex with men. Vaccine. 2026. PMID: 42822177. doi:10.1016/j.vaccine.2026.129193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。